Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (69 ops.)
Latest filing published 20 Feb 2026 for PTC Therapeutics, INC., €177k.
Filing timeline
BuySaleEric Pauwels
Insider track record
Disclosed buys
0
Disclosed sells
69
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Eric Pauwels: trading record in brief
Eric Pauwels (senior executive) discloses dealings in PTC Therapeutics, Inc. to SEC (Form 4). The record holds 93 filings, for trades running from 16 April 2020 to 18 February 2026.
Every open-market trade on record is a sale: 69 sales worth €9.6M. Outside the open market, there are 8 share grants and 16 option exercises. 2026 to date brings no purchases and 8 sales.
The latest filing, published on 20 February 2026, reports an open-market sale of €177k in PTC Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Pauwels
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
3,019 shares@ US$69.368.6% of flowCommon StockSEC:0001323212-26-000008:0
2,561 shares@ US$76.428.2% of flowCommon StockSEC:0001323212-26-000006:0
1,789 shares@ US$76.955.7% of flowCommon StockSEC:0001323212-26-000004:0
20,000 shares0Common StockSEC:0001323212-26-000002:0
138 shares@ US$66.490.5% of flowCommon StockSEC:0001323212-25-000006:0
1,245 shares@ US$66.494.5% of flowCommon StockSEC:0001323212-25-000003:0
16,698 shares@ US$30.8629.1% of flowCommon StockSEC:0001415889-25-023986:0
4,458 shares@ US$55.1919.7% of flowCommon StockSEC:0001415889-25-008452:0
1,378 shares@ US$50.0965.7% of flowCommon StockSEC:0001415889-25-005137:0
1,599 shares@ US$45.346.1% of flowCommon StockSEC:0001415889-25-001294:0
22,000 shares0Common StockSEC:0001415889-25-001017:0
787 shares@ US$25.1351.6% of flowCommon StockSEC:0001415889-24-011248:0
22,000 shares0Common StockSEC:0001415889-24-004162:0
366 shares@ US$27.25080.8% of flowCommon StockSEC:0001415889-24-002171:0
1,569 shares@ US$28.64033.6% of flowCommon StockSEC:0001415889-24-000917:0
6,403 shares@ US$58.955330.4% of flowCommon StockSEC:0001415889-23-008568:0
800 shares@ US$58.51753.7% of flowCommon StockSEC:0001415889-23-008390:0
732 shares@ US$52.04373.0% of flowCommon StockSEC:0001415889-23-006752:0
375 shares@ US$45.6281.4% of flowCommon StockSEC:0001415889-23-001800:0
359 shares@ US$47.45131.4% of flowCommon StockSEC:0001415889-23-001460:0
663 shares@ US$42.93292.3% of flowCommon StockSEC:0001415889-23-000878:0
858 shares@ US$41.65622.9% of flowCommon StockSEC:0001415889-23-000835:0
18,000 shares0Common StockSEC:0001415889-23-000690:0
822 shares@ US$42.5150.9% of flowCommon StockSEC:0001415889-22-004210:0
367 shares@ US$40.0020.4% of flowCommon StockSEC:0001179110-22-000839:0
25 of 28 declarations
